ATNM news

Latest 2 stories · newest Oct 15, 2026

ATNM
Actinium Appoints Dr. Matt David as CFO

Actinium Pharmaceuticals announced the appointment of Matt David, M.D., as Chief Financial Officer to lead finance and capital markets functions. This strategic leadership addition may enhance investor relations as the company advances its targeted radiotherapy pipeline.

Leadership Oct 15, 2026 sentiment +0.20 SEC filing ↗
ATNM
Actinium to present ATNM-400 data at SNMMI 2026; receives NYSE American listing notice

Actinium Pharmaceuticals announced it will present updates on its ATNM-400 Actinium-225 antibody radioconjugate program across three presentations at the SNMMI 2026 conference, showcasing data in prostate cancer and NSCLC. The company also received a notice of non-compliance with NYSE American conti…

Regulatory May 29, 2026 sentiment -0.30 SEC filing ↗
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same ATNM feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/ATNM/newsSTART FREE